Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Pulmonary Disease, Chronic ObstructiveObesity Hypoventilation SyndromeMetabolic Alkalosis
Interventions
DRUG

Acetazolamide

"Daily morning ABGA:~* If actual bicarbonate \> 26 mmol/L and pH \> 7.35: administration of enteral capsule of acetazolamide 500 mg .~* If actual bicarbonate \> 26 mmol/L and pH \<= 7.35, increase minute ventilation to reach pH \> 7.35 and then administer enteral capsule of acetazolamide 500 mg.~* If actual bicarbonate \<= 26 mmol/L: omit treatment that day."

DRUG

Placebo

"Daily morning ABGA:~* If actual bicarbonate \> 26 mmol/L and pH \> 7.35: administration of enteral capsule of placebo.~* If actual bicarbonate \> 26 mmol/L and pH \<= 7.35, increase minute ventilation to reach pH \> 7.35 and then administer enteral capsule of placebo.~* If actual bicarbonate \<= 26 mmol/L: omit treatment that day."

Trial Locations (8)

28031

Hospital Universitario Infanta Leonor, Madrid

28040

Fundación Jiménez Díaz, Madrid

07500

Hospital de Manacor, Manacor

07010

Hospital Son Espases, Palma de Mallorca

07198

Hospital Son Llàtzer, Palma de Mallorca

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

08402

Fundació Hospital Asil de Granollers, Granollers

08970

Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí

All Listed Sponsors
lead

Hospital Son Llatzer

OTHER

NCT01499485 - Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation. | Biotech Hunter | Biotech Hunter